On Day 28 , pre-dose FEV1 showed FF 200 g OD to be non-inferior ( pre-defined limit -110 ml ) to FF 100 g BD ( mean treatment difference 11 ml ; 95 % CI : -35 to +56 ml ) ; all FF and FP regimens were significantly superior to placebo ( p 0.02 ) .
